SC

Superstring Capital

North America, New York, United States, New York

Description

Superstring Capital is a venture capital firm.

Investor Profile

Superstring Capital has made 12 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series C (33%)
  • Post Ipo Equity (8%)
  • Series E (8%)

Country Focus

  • United States (58%)
  • China (42%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
  • Health Diagnostics
  • Therapeutics
  • Life Science
  • Genetics
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Superstring Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 4
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Enavate Sciences
North America, New York, United States, New York
Co-Investments: 2
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

What are some of recent deals done by Superstring Capital?

Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series CMay 7, 2024
Amount Raised: $200,000,000
Century Therapeutics

Philadelphia, Pennsylvania, United States

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

BiotechnologyHealth CareHealth Diagnostics
Post Ipo EquityApr 11, 2024
Amount Raised: $60,000,000
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series BNov 7, 2022
Amount Raised: $118,000,000
Sironax

Beijing, Beijing, China

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BAug 2, 2022
Amount Raised: $200,000,000
Shoreline Biosciences

La Jolla, California, United States

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

BiotechnologyHealth CareLife ScienceMedical
Series BNov 2, 2021
Amount Raised: $140,000,000
ReCode Therapeutics

Dallas, Texas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

BiopharmaBiotechnologyGeneticsPharmaceutical
Series BOct 21, 2021
Amount Raised: $80,000,000
dMed

Shanghai, Shanghai, China

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.

BiopharmaMedicalPharmaceutical
Series CJul 10, 2021
Amount Raised: $50,000,000
Clinipace

Morrisville, North Carolina, United States

Clinipace is a clinical research firm that offers integrated clinical research services for biopharmaceutical and medical firms.

BiotechnologyClinical TrialsMedical
Series CJul 8, 2021
Amount Raised: $50,000,000
Elpiscience Biopharmaceuticals

Shanghai, Shanghai, China

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

BiopharmaBiotechnologyHealth CarePharmaceutical
Series CMay 13, 2021
Amount Raised: $105,000,000
AffaMed Therapeutics

New City, New York, United States

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Biotechnology
Series BMar 30, 2021
Amount Raised: $170,000,000